Welcome to our dedicated page for Canton Strategic Holdings SEC filings (Ticker: CNTN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Canton Strategic Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Canton Strategic Holdings's regulatory disclosures and financial reporting.
Canton Strategic Holdings, Inc. has completed the sale of all membership interests in its clinical-stage biotech subsidiary, Gravitas Life Sciences, LLC, to Gravitas Collective Corp., an entity affiliated with former directors. Consideration consists of an unsecured $3,500,000 Gravitas Note bearing 15% per-annum, payable-in-kind interest, maturing on July 17, 2029, plus potential development milestone payments. A special committee of independent, non-interested directors reviewed and unanimously approved the transaction, which the full board also approved. Gravitas’ bispecific antibody development assets were retained through subsidiary Tharimmune SPV1.
Pro forma financial statements for March 31, 2026 and for 2025 present Canton Strategic without Gravitas. On a pro forma basis, total assets at March 31, 2026 are $586,523,091, including $541,569,363 of digital assets and the new $3,500,000 note receivable, and stockholders’ equity is $472,023,616. Pro forma net loss is $45,544,391 for the quarter ended March 31, 2026 and $25,816,965 for the year ended December 31, 2025. The company states that this divestiture supports its focus on digitizing financial markets through the Canton Network.
Canton Strategic Holdings, Inc. held its 2026 annual meeting of stockholders on July 13, 2026. As of the June 16, 2026 record date, 77,122,584 shares of common stock were outstanding, and 25,792,741 shares were represented in person or by proxy, constituting a quorum. Stockholders elected seven directors to serve until the 2027 annual meeting, with each nominee receiving at least 25,490,487 votes for, small numbers of abstentions, and no broker non-votes reported.
Stockholders also ratified the appointment of Rosenberg Rich Baker Berman P.A. as independent registered public accounting firm for the fiscal year ending December 31, 2026, by 25,780,986 votes for, 3,980 against and 7,775 abstaining. At a July 15, 2026 special board meeting, the board appointed members and chairs for its Audit, Compensation, and Nominating and Governance Committees, with Sean Galvin, William Wiley, and Jill E. Sommers serving as the respective chairs.
Canton Strategic Holdings, Inc. director Rishi Nangalia filed an initial Form 3 as a reporting person for CNTN. The filing lists no reportable transactions and no derivative securities, indicating that, as of this filing, no equity or option holdings are disclosed for this insider.
Canton Strategic Holdings, Inc. reported the initial beneficial ownership position of director Pamela L. Carter. She is identified as a director and not a ten percent owner, and no equity or derivative securities or insider transactions are reported for her at the time of this statement.
Canton Strategic Holdings, Inc. reports that Sean Galvin has filed an initial Form 3 as a reporting person. He is identified as a director, not an officer or a ten percent owner, and the form shows no reported transactions or currently reported holdings or derivatives.
Canton Strategic Holdings, Inc. Schedule 13G/A reports that ARK Investment Management LLC and Catherine D. Wood beneficially own 3,657,548 shares of Common Stock, representing 4.74% of the class as of 06/30/2026.
The filing states ARK has sole voting and dispositive power over 3,657,548 shares while Catherine D. Wood has shared voting and dispositive power over 3,657,548 shares. The amendment is signed on 07/08/2026.
Canton Strategic Holdings, Inc. is holding its 2026 annual stockholders meeting as a fully virtual event on July 13, 2026 at 2:00 p.m. Eastern Time. Stockholders of record as of June 16, 2026, when 77,122,584 common shares were outstanding, are entitled to vote.
Investors are being asked to elect seven directors and to ratify Rosenberg Rich Baker Berman P.A. as independent auditor for the year ending December 31, 2026. Six of the seven director nominees are classified as independent under Nasdaq rules, and all key board committees are composed of independent directors.
The proxy details an insider trading policy that bans short sales, hedging and pledging without pre-approval, and outlines executive pay. For 2025, former interim CEO Sireesh Appajosyula received total compensation of $2,881,544, while current CEO Mark Wendland received $358,333 after his November 2025 appointment. The company maintains multiple equity incentive plans and has significantly expanded share reserves under its 2023 Omnibus Equity Incentive Plan.
Canton Strategic Holdings, Inc. authorized a share repurchase program of up to $50 million of its common stock, approved by the Board of Directors on June 11, 2026. The company may buy shares in open-market or privately negotiated transactions in line with Rule 10b-18.
On June 12, 2026, Canton Strategic entered a Rule 10b-18 Repurchase Agreement with Virtu Americas LLC, which will act as a non-exclusive agent to execute open-market repurchases. Canton Strategic will pay Virtu a $0.02 commission per share repurchased. The timing and total amount of repurchases are discretionary and the program can be modified, suspended, or terminated by the Board.
Canton Strategic Holdings, Inc. director Gary S. Stetz reported open-market sales of company Common Stock. He sold a total of 100,351 shares in multiple transactions on May 22, 2026 and May 26, 2026 at prices ranging from $3.40 to $3.47 per share. After these sales, he directly owns 134,175 shares of Canton Strategic Holdings Common Stock.
Canton Strategic Holdings reported a sharp increase in scale and a much larger loss for the quarter ended March 31, 2026, reflecting its pivot to a digital asset treasury strategy built around Canton Coin (CC). Total assets rose to $584.7 million, driven mainly by CC holdings with a fair value of $541.6 million and cash of $41.5 million.
The company posted a quarterly net loss of $47.3 million versus $2.5 million a year earlier, largely due to $36.9 million in operating expenses and a $15.0 million unrealized loss on CC. General and administrative costs surged to $36.6 million, including $32.3 million of stock-based compensation linked to its capital markets and strategic advisory arrangements.
To fund the new strategy, Canton raised substantial capital: a January 2026 registered direct offering plus at-the-market sales and warrant exercises generated about $87.0 million of financing cash inflows during the quarter, following more than $537 million of private placement proceeds in November 2025. Management believes existing liquidity can support operations through at least March 2027 while it runs both the CC-centric treasury segment and its legacy clinical-stage biotechnology programs.